NewswireToday (newswire) - 02/04/2008 London, United Kingdom - New analysis from Frost & Sullivan, European Immunochemistry Analysers Market, estimates that the market will be worth $164.7 million in 2007 and will reach $412.4 million by 2012 Read more…

NewswireToday (newswire) - 02/06/2008 London, United Kingdom - New analysis from Frost & Sullivan, Services Opportunities in LSIT in Europe, finds that the market generated revenues of $100 million in 2006 and estimates this to triple by 2013 to reach $300 million Read more…

NewswireToday (newswire) - 01/31/2008 San Jose, CA United States - Continuing to rapidly expand its antibody offerings, AnaSpec added nine (9) new antibody products to its growing collection Read more…

NewswireToday (newswire) - 01/31/2008 London, Greater London United Kingdom - eyeforpharma, announced today that the 5th annual Patient Compliance & Communication conference, London, 11-12 June 2008 has secured its full speaker faculty including leading executives from Pharma, Payers and Stakeholder groups Read more…

NewswireToday (newswire) - 01/29/2008 Muenster, North Rhine-Westfalia Germany - German service providers for the pharmaceutical industry merge, trading under the new name Diapharm Read more…

NewswireToday (newswire) - 01/29/2008 London, United Kingdom - New analysis from growth consulting company Frost & Sullivan, European Non-Hodgkin's Lymphoma Therapeutics Markets, finds that the market earned revenues of $2.2 billion in 2006 and estimates this to reach $7.2 billion in 2013 Read more…

Health boards across Scotland are looking into introducing registers for all medical staff to allow them to declare if they have any links with drug companies. The news comes following fears that some of the world's pharmaceutical giants have too much influence over what drugs some doctors prescribe. NHS Greater Glasgow has told the Herald that following a consultation it hopes to have a register, which would be publicly available, in place by June. Read more…

The Medicines and Healthcare products Regulatory Agency (MHRA) has found that Napp Pharmaceuticals broke its advertising rules. A complaint was lodged about the firm's advert for the painkiller BuTrans (buprenorphine matrix patch) in the British Medical Journal in November 2005. Read more…

A pharmacy care program for elderly patients increases medication adherence according to a study appearing in JAMA. Read more…

FDA informs public of nationwide recall of 500mg strength store-brand acetaminophen caplets. Read more…

Dr Sami Timimi gives a lucid account of the socio-cultural context behind the rising rates of prescription of psycho-stimulants for children. Read more…

Gordon Brown’s recent speech on the limits of market mechanisms did not go quite far enough, argues Margaret CookWhen great men make great speeches it has been remarked that the content is often not as impressive in the reading as in the hearing. Read more…

Proposals to deregulate the market for community pharmacy may end up cutting services patients need, says Richard LewisTo the casual observer, the Office of Fair Trading seems to have it in for community pharmacists. Read more…

Most health research is driven by commercial interests, leading to significant gaps in healthcare understanding, a report from the King’s Fund thinktank concludes. Read more…

Thousands of gene patents have been issued – yet in most cases they are not inventions, and patenting harms the public interest, warns Sue MayerFor some years a fierce argument has been raging over whether genes should be patentable. Read more…

Many deaths in developing countries could be avoided if essential drug prices were lowered. Ken Bluestone explains how pharmaceutical companies are being urged to take their social responsibilities seriouslyWhy not lower drugs prices systematically for developing countries? Read more…

Too many people who visit their GP with mental health problems are being offered drugs as the only option, according to the mental health charity Mind which has launched a campaign for more choice. Read more…

Dear healthmatters — Further to your report ‘Global pressure leads to falling drug prices’ (issue 44) the pharmaceutical industry is indeed fighting hard – and dirty. Read more…

Consultant psychiatrists joined forces with mental health service user groups in July to demonstrate against the ‘hijacking’ of mental health care by the pharmaceutical industry. Read more…

Read more…